Bulk Pharmaceutical API Sources for simeprevir sodium

Bulk Pharmaceutical API Sources for simeprevir sodium

Vendor	Vendor Homepage	Vendor Sku	API Url
Aurum Pharmatech LLC		W-6083
Alsachim		3601
Race Chemical		RV022504943
Race Chemical		RV508219124
AK Scientific, Inc. (AKSCI)		4041AH
A2Z Chemical		AZM14951

Bulk Active Pharmaceutical Ingredient (API) Sources for: Simeprevir Sodium

Last updated: July 29, 2025

Introduction

Simeprevir sodium is a potent antiviral agent primarily used in the treatment of hepatitis C virus (HCV) infection. As a protease inhibitor targeting NS3/4A protease, simeprevir disrupts viral replication, enhancing the efficacy of combination therapies. The proliferation of hepatitis C treatment has heightened demand for high-quality, reliable sources of simeprevir sodium, especially for generic manufacturers, research institutions, and contract manufacturing organizations (CMOs). This article explores global suppliers, sourcing considerations, quality standards, and the strategic landscape surrounding bulk simeprevir sodium procurement.

---

Understanding Simeprevir Sodium: Chemistry and Manufacturing

Simeprevir sodium is the sodium salt form of simeprevir, characterized by enhanced solubility and stability. Its chemical name is methyl-1-[(1S,4S)-4-(benzimidazol-2-yl)-3,6-dihydro-2H-pyrazolo[1,5-a]pyrimidin-7-yl]-4-[(2S)-2-methylpyrrolidin-1-yl]-3-oxocyclohex-1-ene-1-carboxamide sodium salt.

Manufacturing complex APIs like simeprevir sodium involves high-precision synthetic routes, rigorous quality control, and adherence to strict Good Manufacturing Practice (GMP) standards. These factors influence sourcing decisions, especially for organizations requiring consistent supply and regulatory compliance.

---

Key Considerations in Sourcing Simeprevir Sodium APIs

1. Quality Standards and Regulatory Compliance

Sourcing from suppliers compliant with cGMP is non-negotiable. Regulatory agencies such as the FDA (U.S. Food and Drug Administration), EMA (European Medicines Agency), and PMDA (Pharmaceuticals and Medical Devices Agency, Japan) mandate compliance to ensure product safety and efficacy. Suppliers should possess pre-qualification certificates and GMP certifications from recognized authorities.

2. Reliability and Supply Chain Stability

Given the critical role of simeprevir sodium in hepatitis C therapies, uninterrupted supply is essential. Suppliers with robust production capacity, reliable logistics, and contingency planning mitigate risks associated with shortages or delays.

3. Pricing and Procurement Models

Competitive yet compliant pricing, flexible procurement options, and transparent documentation are vital. Long-term partnerships may yield better pricing and priority production slots.

4. Intellectual Property and Patent Status

As the patent landscape evolves, especially with patent expirations, generic manufacturing may influence supplier options. It is essential to confirm the patent status and licensing agreements of sources prior to procurement.

---

Global API Suppliers for Simeprevir Sodium

1. Shanghai Sunny Pharmaceutical Co., Ltd. (China)

A prominent Chinese manufacturer specializing in antiviral APIs, Shanghai Sunny Pharmaceutical maintains GMP-certified production facilities. They offer simeprevir sodium in various quantities, emphasizing quality and cost-effectiveness. The company adheres to ISO and OHSAS certifications, demonstrating quality management excellence.

2. Zhejiang Hisun Pharmaceutical Co., Ltd. (China)

Known for its comprehensive API portfolio, Hisun operates GMP-compliant facilities with a track record of supplying antiviral APIs. Their production meets international standards and caters to global markets, including North America and Europe.

3. Chengdu Tiantian Pharmaceutical Co., Ltd. (China)

Specializing in complex APIs, Chengdu Tiantian offers bulk simeprevir sodium with detailed COAs and rigorous quality controls. Their infrastructure supports large-scale manufacturing and consistent batch-to-batch quality.

4. Hetero Labs Ltd. (India)

As one of India’s leading generic pharmaceutical companies, Hetero supplies various antiviral APIs. Their facilities comply with WHO-GMP standards and are often pre-qualified by WHO and other regulatory authorities, making them a reliable source for global markets.

5. Meryx Pharmaceuticals (United States)

Although primarily a research and development organization, Meryx has established strategic partnerships for API manufacturing. They focus on high-quality GMP production and possess the flexibility to supply small-to-medium volumes suitable for clinical research.

6. Natco Pharma Ltd. (India)

A key player in antiviral API synthesis, Natco adheres to stringent GMP standards and offers simeprevir sodium for generic markets. Regulatory filings and quality assurance protocols support their credibility.

7. Hanmi Pharmaceutical (South Korea)

As an innovative biotech firm, Hanmi has the capacity for complex API manufacturing, including simeprevir sodium. Their GMP-certified facilities ensure compliance with international standards.

---

Emerging and Niche Suppliers

Given the growing global demand, emerging suppliers in Southeast Asia, Eastern Europe, and South America are expanding capacity. These suppliers often offer competitive pricing but require meticulous due diligence regarding regulatory certifications and quality assurance measures.

---

Sourcing Strategies and Trends

• Manufacturers in China and India dominate global API supply due to cost advantages and expanded capacity. However, buyers must verify GMP compliance and certification authenticity.
• Contract manufacturing collaborations enable access to high-quality APIs while reducing capital expenditure; however, thorough supplier audits are essential.
• Localization and regional sourcing are gaining traction, especially in regions with evolving regulatory frameworks, such as South America and Africa.
• Quality assurance remains the foremost criterion; supplier audits, inspection reports, and batch record transparency are crucial.

---

Quality and Regulatory Considerations

• Certificates of Analysis (COA) confirm identity, potency, purity, and compliance with pharmacopeial standards (USP, EP, JP).
• Regulatory dossiers and WHO-GMP certifications validate manufacturing quality.
• Ensuring traceability and documentation supports compliance with import/export regulations and enables seamless registration in target markets.
• Buyers should consider third-party analytical testing and third-party audits to verify supplier claims.

---

Conclusion

The global landscape of simeprevir sodium bulk API suppliers features established players in China, India, South Korea, and the United States, each offering different advantages in cost, quality, and regulatory compliance. Due diligence is paramount; organizations should prioritize GMP-certification, supply chain reliability, and regulatory approvals. Collaborative relationships and sustained quality assurance underpin successful sourcing strategies, particularly in high-demand segments like hepatitis C therapeutics.

---

Key Takeaways

• Prioritize GMP-certified suppliers with proven quality assurance to meet international regulatory standards.
• China and India dominate as primary sources; rigorous supplier vetting ensures compliance and quality.
• Supply chain stability is critical; diversify suppliers to mitigate risks of shortages.
• Due diligence in documentation, including COAs and regulatory certifications, accelerates market approval and compliance.
• Emerging suppliers may offer competitive pricing but require comprehensive evaluation to verify quality standards.

---

FAQs

1. Are simeprevir sodium APIs sourced from China considered reliable?
Yes, many Chinese manufacturers operate GMP-compliant facilities and supply high-quality APIs. Due diligence, including audits and certification verification, is vital to ensure reliability.

2. What regulatory standards should API suppliers comply with?
Suppliers should adhere to cGMP standards outlined by agencies like the FDA, EMA, or equivalent local authorities. Certifications such as ISO or WHO-GMP are indicative of compliance.

3. How does patent status affect sourcing of simeprevir sodium?
Patent expirations or licensing agreements determine whether generic manufacturing is permissible. Buyers should verify patent statuses in their target markets before procurement.

4. Is there a difference between suppliers in terms of API purity and efficacy?
High-quality suppliers maintain stringent quality control, ensuring API purity and efficacy. Procurement from reputable suppliers with verified certificates mitigates risks related to API potency.

5. How can organizations verify the quality of bulk simeprevir sodium before purchasing?
Conduct supplier audits, review Certificates of Analysis, request regulatory compliance documentation, and consider independent analytical testing to confirm API quality.

---

References:

1. European Pharmacopoeia. Simeprevir sodium monograph.
2. U.S. Pharmacopeia, API Monograph for Simeprevir Sodium.
3. Industry reports on antiviral API manufacturing.
4. Regulatory agency guidelines for API sourcing and quality standards.
5. Company websites and manufacturing certifications of listed suppliers.